These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12826842)

  • 21. Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices.
    Falter F; Razzaq N; John M; Fassl J; Maurer M; Ewing S; Hofmeyr R
    J Extra Corpor Technol; 2018 Mar; 50(1):38-43. PubMed ID: 29559753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
    Wallock M; Jeske WP; Bakhos M; Walenga JM
    Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
    Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Hemochron Response RxDx heparin and protamine dosing system.
    Jaryno SA; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-Care Measurement of Kaolin Activated Clotting Time during Cardiopulmonary Bypass: A Single Sample Comparison between ACT Plus and i-STAT.
    Vranken NPA; Theelen AJAJ; Orbons T; Barenbrug PJC; Weerwind PW
    J Extra Corpor Technol; 2021 Mar; 53(1):57-61. PubMed ID: 33814607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New technology, old standards: disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron.
    Aylsworth CL; Stefan F; Woitas K; Rieger RH; LeBoutillier M; DiSesa VJ
    Ann Thorac Surg; 2004 Mar; 77(3):973-6. PubMed ID: 14992909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ACT point-of-care measurements: repeatability and agreement.
    Bosch YP; Ganushchak YM; de Jong DS
    Perfusion; 2006 Jan; 21(1):27-31. PubMed ID: 16485696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
    Hellstern P; Bach J; Simon M; Saggau W
    J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass.
    Li H; Serrick C; Rao V; Yip PM
    Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of three activated clotting time point-of-care systems in cardiac surgery: reinforcing available evidence.
    Solís Clavijo D; Cotano AO; Peña NA; Caballero Gálvez S; Arellano Núñez F; Carballo Caro JM; Muñoz-Cacho P; Tocón Alé C
    Perfusion; 2022 Oct; 37(7):711-714. PubMed ID: 34109886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
    Schroeder AP; Knudsen LL; Husted SE; Knudsen L; Ingerslev J
    J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The activated clotting time in cardiac surgery: should Celite or kaolin be used?
    De Vries AJ; Lansink-Hartgring AO; Fernhout FJ; Huet RCG; van den Heuvel ER
    Interact Cardiovasc Thorac Surg; 2017 Apr; 24(4):549-554. PubMed ID: 28108578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of different anticoagulant agents on fibrinopeptide a generation.
    Tobu M; Iqbal O; Messmore HL; Ma Q; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2003 Oct; 9(4):273-92. PubMed ID: 14653437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
    El Rouby S; Rinehart K; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the i-STAT handheld activated clotting time for use with bivalirudin.
    Schussler JM; Lander SR; Wissinger LA; Anwar A; Donsky MS; Johnson KB; Vallabhan RC; Wischmeyer JB
    Am J Cardiol; 2004 May; 93(10):1318-9. PubMed ID: 15135717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celite and kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy.
    Feindt P; Seyfert UT; Volkmer I; Straub U; Gams E
    Thorac Cardiovasc Surg; 1994 Aug; 42(4):218-21. PubMed ID: 7529949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Standard Point-of-Care Hemochron Jr. ACT+ Test in Monitoring Heparin Administration for Cardiopulmonary Bypass in Severe Factor XII Deficiency.
    Erkinaro T; Moilanen J; Lahtinen J; Mosorin M; Savolainen ER
    J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):2031-2034. PubMed ID: 34130893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated clotting time or activated partial thromboplastin time as the method of choice for patients undergoing neuroradiological intervention.
    Kubalek R; Berlis A; Schwab M; Klisch J; Schumacher M
    Neuroradiology; 2003 May; 45(5):325-7. PubMed ID: 12669158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron
    Hoffmann RF; Horsten S; Mariani MA; de Vries AJ
    Perfusion; 2023 Mar; 38(2):285-291. PubMed ID: 34596463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.